Will Hydroxychloroquine Impede or Prevent COVID-19

Clinical trial NCT04341441 · TERMINATED

Trial details

NCT number: NCT04341441
Sponsor: Henry Ford Health System
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Coronavirus Coronavirus Infections SARS-CoV 2

Start date: 2020-04-07
Primary completion: 2020-12-15
Enrollment: 624

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.